(EYEG) Eyegate Pharmaceuticals complete technical analysis [charts+indicators] | Buy/Sell Eyegate Pharmaceuticals | (EYEG) share price targets
Complete technical analysis of Eyegate Pharmaceuticals (EYEG) by charts plus indicators, forecast predictions and share price targets for Eyegate Pharmaceuticals (EYEG)
Eyegate Pharmaceuticals trades in USA in Health Care sector.
10 day averaged volume of Eyegate Pharmaceuticals is 2230
Date | Daily Closing Price | Open | High | Low | Volume |
04 Fri Apr 2025 | 35.46 | 35.59 | 35.60 | 35.40 | 3.991 times |
03 Thu Apr 2025 | 35.56 | 35.62 | 35.62 | 35.56 | 0.045 times |
02 Wed Apr 2025 | 35.51 | 35.50 | 35.51 | 35.50 | 0.045 times |
01 Tue Apr 2025 | 35.48 | 35.54 | 35.66 | 35.48 | 9.148 times |
31 Mon Mar 2025 | 35.54 | 35.45 | 35.54 | 35.45 | 0.045 times |
28 Fri Mar 2025 | 35.48 | 35.48 | 35.48 | 35.48 | 0.045 times |
24 Mon Mar 2025 | 35.41 | 35.43 | 35.44 | 35.41 | 0.269 times |
21 Fri Mar 2025 | 35.55 | 35.55 | 35.55 | 35.55 | 0.045 times |
20 Thu Mar 2025 | 35.60 | 35.60 | 35.60 | 35.60 | 0.045 times |
19 Wed Mar 2025 | 35.60 | 35.58 | 35.60 | 35.58 | 0.269 times |
Stock of Eyegate Pharmaceuticals (EYEG) has showed a significant fall. This could be a good time to exit from this stock.
My analysis of stock is bearish for shortterm, and stock might move down till 35.4 or till 35.3. Use a stoploss of 35.47 and if the stock hits stoploss, then it can shoot up till 35.56
Share price targets for Eyegate Pharmaceuticals (EYEG)
Target Type | Value |
Downside Target | 34.56 |
Upside Target | 35.48 |
Upside Target | 35.57 |
Upside Target | 35.60 |
Upside Target | 35.66 |
Upside Target | 35.81 |
Upside Target | 36.44 |
Intraday share price targets for Eyegate Pharmaceuticals (EYEG)
Target Type | Value |
Downside Intraday Target | 35.35 |
Downside Intraday Target | 35.25 |
Upside Intraday Target | 35.61 |
Upside Intraday Target | 35.77 |
Upside Intraday Target | 35.51 |
Weekly technical analysis of Eyegate Pharmaceuticals (EYEG)
Date | Weekly Closing Price | Open | High | Low | Volume |
04 Fri Apr 2025 | 35.46 | 35.45 | 35.66 | 35.40 | 42.286 times |
28 Fri Mar 2025 | 35.48 | 35.43 | 35.48 | 35.41 | 0.7 times |
21 Fri Mar 2025 | 35.55 | 35.35 | 35.60 | 35.35 | 0.213 times |
14 Fri Mar 2025 | 35.32 | 35.57 | 35.57 | 35.26 | 0.623 times |
07 Fri Mar 2025 | 35.43 | 35.73 | 35.81 | 35.43 | 15.082 times |
Price has moved down this week, and volume has increased substantially. This means that the move can continue in coming weeks.
Monthly technical analysis of Eyegate Pharmaceuticals (EYEG)
Date | Monthly Closing Price | Open | High | Low | Volume |
04 Fri Apr 2025 | 35.46 | 35.54 | 35.66 | 35.40 | 2.101 times |
31 Mon Mar 2025 | 35.54 | 35.73 | 35.81 | 35.26 | 0.6 times |
28 Fri Feb 2025 | 35.81 | 35.15 | 35.81 | 35.01 | 1.2 times |
31 Fri Jan 2025 | 35.18 | 34.97 | 35.31 | 34.56 | 0.187 times |
Scroll below to view daily charts
Price has moved down this month, and volume has increased substantially. This means that the move can continue in coming months.
Indicators analysis of Eyegate Pharmaceuticals (EYEG)
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eyegate Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Eyegate Pharmaceuticals in short term but the sell signal is initial and weak.
Eyegate Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Eyegate Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyegate Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 35.48 and Eyegate Pharmaceuticals (EYEG) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyegate Pharmaceuticals (EYEG) stock. Volume based technical analysis of Eyegate Pharmaceuticals (EYEG) stock is negative.
Eyegate Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a short to mid term time period is negative, but trend is highly volatile. A longer duration price action analysis might give a better picture of the trend in this stock.
Price action analysis of Eyegate Pharmaceuticals ( (EYEG) ) based on a mid to longer term time period is definitely negative. This means that there is a strong downtrend in the stock for given time period. Sellers are extremely active on this stock.
ADX buy sell signal for Eyegate Pharmaceuticals stock for short term is SELL. Signal strength is Weak and stock is losing momentum.
MACD generated a SELL signal for Eyegate Pharmaceuticals in short term but the sell signal is initial and weak.
Eyegate Pharmaceuticals Stock in short term is moving inside a range for now. Please check in a day or two to for a better buy sell signal. Bears are getting stronger in this stock.
Ichimoku cloud is of green color and prices are in or below the green cloud Prices appear to be coming down
CCI has generated a SELL signal for Eyegate Pharmaceuticals in short term and SELL signal is strong!
RSI is generating a SELL signal in short term and selling is picking up momentum.
MRSI is in positive zone. This is a BUY zone
Although the stock is in the BUY zone, but buying might be slowing down
Stock of Eyegate Pharmaceuticals is picking up selling momentum according to indicator.
Volume based indicators are showing selling momentum.
Volume Weighted Averaged Price (VWAP) for short term is 35.48 and Eyegate Pharmaceuticals (EYEG) stock is trading below this level. This means that stock is falling with high volumes. VWAP is falling down
People seem to be coming out and selling the Eyegate Pharmaceuticals (EYEG) stock. Volume based technical analysis of Eyegate Pharmaceuticals (EYEG) stock is negative.
Eyegate Pharmaceuticals Stock is giving positive returns over a short term period. Returns for a longer term period have been positive
Force Index is moving in a negative zone, which indicates selling momentum for short term... Selling momentum is getting weaker.